Entospletinib with decitabine in acute myeloid leukemia with mutant <i>TP53</i> or complex karyotype: A phase 2 substudy of the Beat AML Master Trial
Vu H. Duong(University of Maryland, Baltimore), Michael Boyiadzis(UPMC Hillman Cancer Center), William Blum(The Ohio State University), Wendy Stock(University of Chicago), Uma Borate(The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute), Martha Arellano(Memorial Sloan Kettering Cancer Center), Alice S. Mims(The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute), Ross L. Levine(Memorial Sloan Kettering Cancer Center), Sonja Marcus(Leukemia and Lymphoma Society), Matthew C. Foster(University of North Carolina at Chapel Hill), Theophilus J. Gana(LEK Consulting (United States)), Ronan Swords(University of Miami), Brian Druker(Oregon Health & Science University), Mona Stefanos(The Ohio State University), James M. Foran(Memorial Sloan Kettering Cancer Center), Jo‐Anne Vergilio(Boston Children's Hospital), Tara L. Lin(Dana-Farber Cancer Institute), Gary J. Schiller(Fred Hutch Cancer Center), Robert L. Redner(UPMC Hillman Cancer Center), Christopher R. Cogle(University of Florida), Maria R. Baer(University of Maryland, Baltimore), Ashley O. Yocum(Leukemia and Lymphoma Society), Franchesca Druggan(The Ohio State University), Eytan M. Stein(Memorial Sloan Kettering Cancer Center), Prapti A. Patel(The University of Texas Southwestern Medical Center), Rebecca L. Olin(University of California, San Francisco), Leonard Rosenberg(Leukemia and Lymphoma Society), Abigail B. Shoben(The Ohio State University), Amy Burd(Leukemia and Lymphoma Society), Mark R. Litzow(Mayo Clinic in Arizona), Robert H. Collins(Texas Oncology), Timothy F. Chen(The University of Sydney), Amy S. Ruppert(The University of Texas MD Anderson Cancer Center), Nyla A. Heerema(The Ohio State University), John C. Byrd(University of Cincinnati), Tibor Kovacsovics(Hôpital Edouard Herriot), Zeina Al‐Mansour(University of Massachusetts Chan Medical School)
Cited by 32
Related Papers
Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling
|Nature|2000|10k
Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel
|Blood|2016|5.9k
The landscape of somatic copy-number alteration across human cancers
|Nature|2010|4.1k